HEALIUS LIMITED — Capital/Financing Update 2018

Aug 19, 2018

ASX Announcement (ASX: PRY)

ASX Limited (Att: Stephanie So) ASX Market Announcements Office Exchange Centre Level 4, 20 Bridge Street Sydney NSW 2000

ACN 064 530 516 ACN 064 530 516 REGISTERED OFFICE: LEVEL 6, 203 PACIFIC HIGHWAY ST LEONARDS NSW 2065 TEL: +61 2 9432 9400 info@primaryhealthcare.com.au

20 August 2018

PRIMARY HEALTH CARE LIMITED ACCELERATED NON-RENOUNCEABLE PRO RATA ENTITLEMENT OFFER NOTICE UNDER SECTION 708AA(2)(f) CORPORATIONS ACT 2001 (CTH)

This notice is given by Primary Health Care Limited (ASX Code: PRY) (“ Primary ”) under section 708AA(2)(f) of the Corporations Act 2001 (Cth) (“ Act ”) as modified by ASIC Corporations (NonTraditional Rights Issues) Instrument 2016/84 (“ Legislative Instrument ”).

Primary has announced an accelerated non-renounceable pro rata entitlement offer (“ Entitlement Offer ”) of 1 fully paid ordinary share in Primary (“ New Share ”) for every 5.21 Primary ordinary shares held as at 7.00 pm (Sydney time) on 22 August 2018 by shareholders with a registered address in Australia, New Zealand and certain other jurisdictions in which Primary decides to extend the Entitlement Offer.

A Retail Information Booklet for the Entitlement Offer is expected to be dispatched to eligible retail shareholders on 27 August 2018.

Primary confirms that:

• (a) the New Shares will be offered for issue without disclosure under Part 6D.2 of the Act;

• (b) this notice is being given under section 708AA(2)(f) of the Act as modified by the Legislative Instrument;

• (c) as at the date of this notice, Primary has complied with:

  • (i) the provisions of Chapter 2M of the Act as they apply to Primary; and

  • (ii) section 674 of the Act;

• (d) as at the date of this notice, there is no excluded information of the type referred to in sections 708AA(8) and 708AA(9) of the Act that is required to be set out in this notice under section 708AA(7) of the Act; and

• (e) the potential effect the issue of New Shares will have on the control of Primary, and the consequences of that effect, will depend on a number of factors, including investor demand and existing shareholdings. Given:

  • (i) the Entitlement Offer is structured as a pro rata issue and is fully underwritten;

  • (ii) the current level of holdings of substantial holders in Primary (based on substantial holding notices that have been given to Primary and lodged with ASX on or prior to the date of this notice) (“ Substantial Holders ”); and

  • (iii) the fact Substantial Holders will not be issued any New Shares pursuant to any institutional or retail shortfall components of the Entitlement Offer, including pursuant to any sub-underwriting arrangement, which would increase their substantial shareholding in Primary above 20% of the total number of ordinary shares on issue in Primary,

1

the issue of the New Shares under the Entitlement Offer is not expected to have a material effect or consequence on the control of Primary.

All queries in relation to the above should be addressed to:

Company Secretary Primary Health Care Limited Level 6, 203 Pacific Hwy St Leonards, NSW 2065

ENDS

2